Arteris, Inc.·4

Jul 8, 4:15 PM ET

Alpern Paul L 4

4 · Arteris, Inc. · Filed Jul 8, 2026

Research Summary

AI-generated summary of this filing

Updated

Arteris (AIP) VP/General Counsel Paul Alpern Sells 6,003 Shares

What Happened

  • Paul L. Alpern, Vice President and General Counsel of Arteris, sold a total of 6,003 shares in open‑market transactions on July 6, 2026, for aggregate proceeds of approximately $215,587. The sales were: 1,824 shares at a weighted avg. $37.13 ($67,724), 1,301 shares at $35.98 ($46,812), and 2,878 shares at $35.11 ($101,051). These were dispositions (sales), which are generally routine but reduce the insider’s holdings.

Key Details

  • Transaction date: July 6, 2026; Form 4 filed July 8, 2026.
  • Total shares sold: 6,003; total proceeds: ~$215,587.
  • Price details: reported as weighted averages with per‑lot ranges — $36.81–$37.57, $35.70–$36.40, and $34.65–$35.40 (the filer can provide exact breakdowns on request).
  • Trading plan: sales were made pursuant to a 10b5‑1 plan adopted by Mr. Alpern on Feb 23, 2026 (footnote F1).
  • Shares owned after the transaction: not specified in the provided filing.
  • Filing timeliness: Form 4 was filed two days after the transactions; no late‑filing notation indicated in the provided data.

Context

  • Because the sales were executed under a preexisting 10b5‑1 trading plan, they were likely scheduled in advance and not necessarily a contemporaneous signal about the company. For retail investors, purchases are typically more informative of positive insider sentiment; planned sales are often for diversification or personal liquidity.

Insider Transaction Report

Form 4
Period: 2026-07-06
Alpern Paul L
VP and General Counsel
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-07-06$37.13/sh1,824$67,72474,912 total
  • Sale

    Common Stock

    [F1][F3]
    2026-07-06$35.98/sh1,301$46,81273,611 total
  • Sale

    Common Stock

    [F1][F4]
    2026-07-06$35.11/sh2,878$101,05170,733 total
Footnotes (4)
  • [F1]Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on February 23, 2026.
  • [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.81 to $37.57 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.70 to $36.40 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.65 to $35.40 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Paul Alpern|2026-07-08

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT